Orca Bio
Tamas Blandl is currently the Vice President of Manufacturing and CMC Development at Orca Bio. Prior to this role, Tamas held leadership positions at NGM Biopharmaceuticals, Medivation, Merck, and other biopharmaceutical companies, with a strong background in process development, CMC functions, and technical operations. Tamas has a PhD in biochemistry from the University of Notre Dame.
This person is not in any teams
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.